Related references
Note: Only part of the references are listed.Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion The 24-Week Results of the VIBRANT Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2015)
Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study)
Ugo Menchini et al.
JOURNAL OF OPHTHALMOLOGY (2015)
Local and Systemic Complications after Intravitreal Administration of Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Different Ocular Diseases: A Five-Year Retrospective Study
Raffaele Nuzzi et al.
SEMINARS IN OPHTHALMOLOGY (2015)
Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study
Yuichiro Ogura et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema: The RESTORE Extension Study
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2014)
Intravitreal Aflibercept for Diabetic Macular Edema
Jean-Francois Korobelnik et al.
OPHTHALMOLOGY (2014)
The Neovascular Age-Related Macular Degeneration Database Report 2: Incidence, Management, and Visual Outcomes of Second Treated Eyes
Javier Zarranz-Ventura et al.
OPHTHALMOLOGY (2014)
Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration
Daniel Barthelmes et al.
OPHTHALMOLOGY (2014)
Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY)
John R. Gonder et al.
JOURNAL OF OPHTHALMOLOGY (2014)
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials RISE and RIDE
David M. Brown et al.
OPHTHALMOLOGY (2013)
Incidence of Choroidal Neovascularization in the Fellow Eye in the Comparison of Age-related Macular Degeneration Treatments Trials
Maureen G. Maguire et al.
OPHTHALMOLOGY (2013)
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
Paul Mitchell et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Ranibizumab for Macular Edema Due to Retinal Vein Occlusions Long-term Follow-up in the HORIZON Trial
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Improved Vision-Related Function after Ranibizumab for Macular Edema after Retinal Vein Occlusion Results from the BRAVO and CRUISE Trials
Rohit Varma et al.
OPHTHALMOLOGY (2012)
Survey of Intravitreal Injection Techniques Among Retinal Specialists in the United States
Amy E. Green-Simms et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
BILATERAL INTRAVITREAL INJECTION OF ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Vinit B. Mahajan et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated in the MARINA and ANCHOR Trials
Irene A. Barbazetto et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Bilateral Simultaneous Intravitreal Injections in the Office Setting
Sophie J. Bakri et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
EVALUATION OF SAFETY FOR BILATERAL SAME-DAY INTRAVITREAL INJECTIONS OF ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Luiz H. Lima et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Ten-year incidence and progression of age-related maculopathy - The Blue Mountains Eye Study
Jie Jin Wang et al.
OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Risk factors for the incidence of advanced age-related macular degeneration in the age-elated eye disease study (AREDS) - AREDS report no.19
RC Milton et al.
OPHTHALMOLOGY (2005)
Share Paper
